| Features: |
| Raloxifene is a type of drug called a selective oestrogen receptor modulator (SERM). Raloxifene is a medication used to treat postmenopausal osteoporosis and the risk reduction of invasive breast cancer in post-menopausal women. |
| Source: |
| Type: |
| P38, or p38 MAPK (p38 mitogen-activated protein kinase), is a protein kinase that plays a significant role in cellular responses to stress, inflammation, and apoptosis (programmed cell death). It is part of the MAPK signaling pathway, which is involved in various cellular processes, including cell growth, differentiation, and survival. It can have both tumor-suppressive and tumor-promoting effects, depending on the type of cancer and the cellular context. -p38 activation can contribute to tumor progression by influencing inflammatory signaling and cell-cycle regulation. -Overexpression can correlate with poor prognosis in some studies. |
| 156- | Ralox, | Tam, | GEN, | CUR, | Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:188 Target#:235 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid